Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials

Vaccine

Volumn 20, Issue 16, 2002, Pages 2131-2139

  Agwale, S M ^a,b   Zeh, C ^b   Robbins, K E ^b   Odama, L ^c   Saekhou, A ^b   Edubio, A ^c   Njoku, M ^d   Sani Gwarzo, N ^e   Gboun, M S ^e   Gao, F ^f   Reitz, M ^a   Hone, D ^a   Pieniazek, D ^b   Wambebe, C ^c   Kalish, M L ^b  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL INSTITUTE FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (Nigeria)

^d UNIVERSITY OF JOS   (Nigeria)

^e Federal Ministry of Health   (Nigeria)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

HIV 1; Molecular epidemiology; Nigeria; Vaccine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; GENE SEQUENCE; GENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTION; HETERODUPLEX ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSURVEILLANCE; NIGERIA; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRAL GENETICS; VIRUS CHARACTERIZATION; VIRUS ENVELOPE; VIRUS IDENTIFICATION; VIRUS RECOMBINANT; VIRUS STRAIN;

AIDS VACCINES; AMINO ACID SEQUENCE; CLINICAL TRIALS; HIV ENVELOPE PROTEIN GP160; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; NIGERIA; PHYLOGENY; RECOMBINATION, GENETIC;

EID: 0037093616     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00059-2     Document Type: Article

References (23)

1. Seroprevalence of HIV-1, HIV-2, and HIV-1 group O in Nigeria: Evidence for a growing increase of HIV infection
2. Human immunodeficiency virus infection in Nigeria
3. Demographic characteristics of retroviral infections (HIV-1, HIV-2, and HTLV-I) among female professional sex workers in Lagos Nigeria
4. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: Genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. WHO network for HIV isolation and characterization
5. Liegeois F, Most env and gag subtype A HIV-1 viruses circulating in west and west central Africa are similar to the prototype AG recombinant virus IbNG
6. Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria
7. Subgroup G HIV type 1 isolates from Nigeria
8. Sequence analysis of the glycoprotein 120 coding region of a new HIV type 1 subtype A strain (HIV-1 IbNG) from Nigeria
9. Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria
10. Predominance of subtype A and G HIV type 1 in Nigeria, with geographic differences in their distribution
11. Development of an env gp41-based heteroduplex mobility assay for rapid HIV-1 subtyping
12. A comprehensive panel of near-full length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1
13. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G
14. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-Bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa
15. Genetic analysis of human immunodeficiency virus in Abidjan Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G